AKORN INC 4
4 · AKORN INC · Filed Feb 23, 2016
Insider Transaction Report
Form 4
AKORN INCAKRX
Lichter Steven
EVP, Pharmaceutical Operations
Transactions
- Award
Stock Options (Right to Buy)
2016-02-19+84,000→ 84,000 totalExercise: $24.95Exp: 2023-02-19→ Common Stock (84,000 underlying)
Footnotes (2)
- [F1]The Stock Options vest in four equal installments on February 19, 2017, February 19, 2018, February 19, 2019 and February 19, 2020.
- [F2]There was no consideration given in exchange for the security.